OMX Nordic 40
2.351,57
PKT
+47,19
PKT
+2,05
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.06.25 | Volvo (B) Underperform | Bernstein Research | |
24.06.25 | Volvo (B) Buy | UBS AG | |
24.06.25 | Novo Nordisk Buy | UBS AG | |
24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
24.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.06.25 | Novo Nordisk Buy | UBS AG | |
18.06.25 | Volvo (B) Underperform | Bernstein Research | |
17.06.25 | Novo Nordisk Buy | UBS AG | |
16.06.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.06.25 | Novo Nordisk Buy | UBS AG | |
13.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
12.06.25 | Volvo (B) Underperform | Bernstein Research | |
12.06.25 | Novo Nordisk Market-Perform | Bernstein Research | |
11.06.25 | Volvo (B) Underperform | Bernstein Research | |
10.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
10.06.25 | Volvo (B) Buy | Deutsche Bank AG | |
10.06.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
09.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
05.06.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
04.06.25 | Volvo (B) Buy | UBS AG | |
04.06.25 | AstraZeneca Hold | Deutsche Bank AG | |
03.06.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.06.25 | AstraZeneca Buy | UBS AG | |
02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
02.06.25 | Novo Nordisk Buy | UBS AG | |
02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
30.05.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
27.05.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
27.05.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
23.05.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG |